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Abstract: The COVID-19 pandemic scenario has a psychological impact on individuals and society.
A higher level of perceived risk concerning COVID-19 has been found when compared to other
potential health threats. A misperception of risk in contrast with the real risk may lead people to
develop disruptive cognitive, affective, or behavioral responses to the COVID-19 pandemic, namely,
coronaphobia. Validated instruments are needed to evaluate such responses. This work aims to
validate the COVID-19 Perceived Risk Scale (C19PRS) and the COVID-19 Phobia Scale (C19PS) in
the Portuguese population. The two scales were translated from English to Portuguese using the
back-translation technique. The cultural adaptation was framed in the context of establishing the
validity and reliability of the instruments. In two studies, C19PRS and C19PS were validated for the
adult Portuguese population (N = 1122; women = 725 (64.6%); mean age of 31.91 years old) through
exploratory factorial analysis, followed by a confirmatory factorial analysis. Convergent validity was
calculated by composite reliability (CR) and average variance extracted (AVE) values. Discriminant
validity was assessed by square roots of the AVE values and their comparison with the C19PRS and
C19PS dimensions’ cross-correlations. Both C19PRS and C19PS present a good adjustment model and
solid reliability and validity and have significant correlations with fear of COVID-19 and COVID-19
anxiety scales.
Keywords: COVID-19 Perceived Risk Scale (C19PRS); COVID-19 Phobia Scale (C19PS); Coronavirus
Anxiety Scale (CAS); Fear of COVID-19 Scale (FCV-19S)
1. Introduction
Coronaviruses are a large family of viruses known to cause diseases ranging from the
common colds to more serious diseases, such as Middle Eastern Respiratory Syndrome
(MERS) and Severe Acute Respiratory Syndrome (SARS) [1]. A new coronavirus outbreak
started in Wuhan city, Hubei Province, China, in December 2019 and January 2020, and
has spread widely across the world since then. The Coronavirus disease 2019 (COVID-19)
evolved as a public health emergency due to its spread within most countries, and was
declared a pandemic by the World Health Organization (WHO) on 11 March 2020 [2]. This
Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) has infected 219,189,790
individuals globally, with 4,544,789 deaths, as of 3 September 2021. In Portugal, the pan-
demic of COVID-19 has infected 1,042,322 infected individuals, with 17,766 mortalities [3].
Being highly infectious, the virus has put pressure on health systems everywhere,
stretching them beyond their capacity and pushing them to disruption [4]. While au-
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thorities strive to monitor outbreak trends and mitigate the pandemic’s impact on health
systems, the economy has been suffering a strong negative impact worldwide, especially in
countries relying on services [5]. This is also the case in Portugal, where whole industries
and jobs are threatened, such as the travel and tourism-related businesses, which accounted
for more than 19% of exports and over 8% of gross domestic product (GDP) in 2019 [6]. This
unsettling scenario has several direct and indirect effects, including on physical and mental
health [7–9]. The outbreak has a psychological impact on individuals and society [10], as
has been reported in different studies, namely, regarding depression, anxiety, stress [7,11],
risk-attitudes [12], fear [13], perceived risk [14] and coronophobia [15]. In fact, Deng and
colleagues [9] found that 45% of COVID-19 patients experience depression, 47% anxiety
and 34% sleep disturbances. Additionally, Wang and colleagues [16] found that the most
common psychological problems were somatization symptoms, depression, anxiety, prob-
lems of insomnia, and self-mutilating or suicidal thoughts. Cielo and colleagues [11] found
a negative psychological impact and a high vulnerability of the young in the development
of psychological distress, highlighting the need for structured and tailored psycholog-
ical support. However, Prati and Mancini [17] stated that the psychological impact of
COVID-19 lockdowns is small in magnitude and highly heterogeneous, suggesting that
most people are psychologically resilient to their effects. In Portugal, there are almost
no validated instruments specifically designed from scratch to assess the psychological
impact of COVID-19. The aim of this study is to validate the COVID-19 Perceived Risk
Scale (C19PRS) and the COVID-19 Phobia Scale (C19PS) in the Portuguese population.
Risk perception is the subjective assessment that people perform about something,
concerning its characteristics, severity, and ways in which the risk can be managed [18].
A higher level of perceived risk was found in relation to COVID-19 as compared to other
potential health threats [19]. According to Slovic [20], the characteristics of risk perception
include (1) voluntariness (the risk of COVID-19 is imposed by external forces and is
uncontrollable, thus being perceived as greater); (2) knowledge (COVID-19 is mostly
unknown and unusual, making the perceived risk more frightening); (3) visibility (COVID-
19 is an invisible risk, making it perceived as more hazardous than a visible one); (4) trust
(the unknown nature of the disease, its repercussion in the mass media) [19]. The high
numbers of infected and dead people, and the difficulty in having a common strategy,
decrease people’s confidence in the management of the pandemic, which leads to a higher
perception of risk. COVID-19 constitutes itself as a risk event that is related not only
to people’s event-related risk perception, but also to their general risk perception [21].
Bruine de Bruin [22] stated that older age was associated with perceiving larger risks of
dying if getting COVID-19, but with perceiving less risk of getting COVID-19, getting
quarantined, or running out of money, as well as less depression and anxiety. Accordingly,
He and colleagues [23] found that the perceived risk of getting COVID-19 increased by
4.9% for every one-year increase in age. Siegrist et al. [24] considered that perceived risks
are important drivers for the acceptance of the government’s implemented measures to
control COVID-19, and for more precautionary behavior.
A misperception of risk in relation to the real risk may lead people to the development
of disruptive cognitive, affective, or behavioral responses to the COVID-19 pandemic,
namely, coronaphobia. Fear is an adaptive animal defense mechanism fundamental for
survival; however, if it is chronic or disproportionate, it may become harmful and can
lead to the development of various psychiatric disorders [25]. According to Amin [26],
coronaphobia is a persistent and excessive fear of the novel coronavirus, being classified as
a particular type of DSM-5-specific phobia. Arpaci et al. [15] stated that natural disasters,
such as the COVID-19 pandemic, can trigger phobic conditions with severe consequences
for mental health. Lee et al. [27] found that coronaphobia explained additional variance in
depression, generalized anxiety, and death anxiety, above sociodemographics, COVID-19
factors, and the vulnerability factors of neuroticism, health anxiety, and reassurance-seeking
behaviors. Additionally, Lee and Crunk [28] reported that neuroticism, coronaphobia, and
hypochondriasis were fear factors that predicted pandemic-related psychopathology in
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adults. Toprak et al. [29] found that individuals who stayed at home had higher corona-
phobia than individuals who continued to work during the 3-month COVID-19 pandemic
lockdown. According to Cihan and Durmaz [30], phobia scores were significantly higher
in women, singles, people living alone, those living in an apartment, and those with higher
economic and educational levels. Durmu and Durar [31] found a significant negative
relationship between spiritual meaning and individuals’ fear of coronavirus, and between
peace and fear of coronavirus. Individuals’ spirituality increases as fear of coronavirus de-
creases. Aware of the negative psychological impact of the pandemic on people, and aware
of the importance of determining the specificity of that impact, Yıldırım and Güler [14]
developed the COVID-19 Perceived Risk Scale (C19PRS), and Arpaci et al. [15] conceived
the COVID-19 Phobia Scale (C19PS). Besides this, Yildirim et al. [32] found that perceived
risk and fear can significantly increase engagement in preventive behaviors. However,
Yildirim and Guler [33] found that COVID-19 perceived risk increases death distress and
reduces happiness. Arpaci and colleagues [34] found a significant positive correlation
between coronaphobia and state anxiety. Additionally, Arpaci and colleagues [35] found
that people were afraid of being infected, and those who got infected were afraid of death.
In Portugal, there are no validated instruments to assess these dimensions; therefore, the
aim of this study is to adapt the C19PRS and the C19PS to the Portuguese population.
2. Materials and Methods
2.1. Sample
Two independent samples were used. The total sample consisted of 1122 participants,
with a mean age of 31.91, who were mostly women without university educations and
were professionally active (Table 1). The EFA sample (n = 561) did not differ from the CFA
sample (n = 561) concerning sociodemographic issues (assessed by chi-square tests and
Student’s t-tests), except for age (t(1111, 613) = 2.22; p = 0.027; d = 0.13), as the EFA sample
was older (M = 32.82 years old; SD = 14.32) than the CFA sample (M = 31.00 years old;
SD = 13.12).













Notes: M = Mean; SD = Standard deviation; N = Frequencies; % = Percentage.
2.2. Procedures
The original authors of the C19PRS [14] and the C19PS [15] gave permission to val-
idate the instrument in a Portuguese population. The two scales were then translated
from English to Portuguese using the back-translation technique [36]. The process of
back-translation included the translation of the previous translation back into its original
language, and then the comparison of the new translation with the previous one, checking
whether the translation conveys the same message as the source text, noting the issues that
may compromise the translation quality, and informing about the parts of the translated
document that may need to be revised again. Cultural adaptation is framed in the context
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of establishing the validity and reliability of the instruments [37]. The translations of
both instruments are available as Appendices A and B (Tables A1 and A2). The protocol
(including the sociodemographic questionnaire; C19PRS, C19PS, FCV-19S and CAS) was
submitted to the ethics committee of the University of Trás-os-Montes e Alto Douro, having
been approved on 1 September 2020 (no specific reference assigned, date acting as reference
ID) and made available online. It was released to the general population through a page
dedicated to the study on a social network, with data being collected between 1 October
and 30 November 2020. All procedures performed in this study adhered to the institutional
research committee’s ethical standards, and the 1964 Helsinki declaration [38] and its later
amendments. Before the investigation protocol, participants were informed about the
research content and its objectives. Confidentiality and anonymity were guaranteed, and
informed consent was obtained.
2.3. Instruments
2.3.1. Sociodemographic Questionnaire
The questionnaire included questions about gender (man vs. woman), age (numer-
ical), education (no university studies vs. university studies), and professional status
(inactive—unemployed, sick, retired, on medical leave—vs. active—students, employees,
housewives).
2.3.2. COVID-19 Perceived Risk Scale (C19PRS)
The authors [14] conceived the COVID-19 related perceived risk by adapting an 8-item
Severe Acute Respiratory Syndrome (SARS) Risk Perception Scale [39], answered on a 5
point Likert scale (1—negligible to 5—very large). The authors [14] changed the wording of
the original items, for example, replacing “SARS” with “COVID-19” and “cancer/accidents”
with “diabetes/asthma”. Examples of items are: “What is the likelihood that you would
die from the COVID-19?” and “How worried are you about contracting the COVID-19?”.
The scale includes a cognitive dimension and an emotional one of personal risk. Higher
scores indicate higher levels of perceived risk related to COVID-19. The authors also found
that the reliability ranged from 0.70 to 0.74 for the cognitive dimension and from 0.84 to
0.88 for the emotional dimension, suggesting satisfactory internal consistency reliability for
the C19PRS.
2.3.3. COVID-19 Phobia Scale (C19PS)
The authors [15] developed this scale to detect COVID-19 phobia early to intervene
as soon as possible. They considered the possibility of this phobia developing due to the
psychological burden caused by COVID-19. The authors [15] developed a structure of 20
items answered on a 5-point Likert scale (1—strongly disagree to 5—strongly agree) and
4 subscales (psychological, psycho-somatic, economic, and social factors). Examples of
items are: “The fear of coming down with coronavirus makes me very anxious” and “I am
extremely afraid that someone in my family might become infected by the coronavirus”.
They also found that the reliability ranged from 0.85 to 0.90 for the four factors and 0.92 for
total, suggesting the good internal consistency and reliability of the C19PS.
2.3.4. Fear of COVID-19 Scale (FCV-19S)
According to Ahorsu et al. [40], the Fear of COVID-19 Scale (FCV-19S) was developed
to complement the clinical efforts made in preventing the spread of and treating COVID-19
cases. The scale was validated in the Portuguese population by Magano et al. [13]. This is a
seven-item scale, answered on a 5-point Likert scale (1—strongly disagree to 5—strongly
agree), with robust psychometric properties (composite reliability—0.88; average variance
extracted—0.5; internal consistency (Cronbach’s α)—0.82), making it reliable and valid in
assessing fear of COVID-19 among the general population and useful in allaying COVID-19
fears among individuals [40]. Examples of items are: “I am most afraid of coronavirus-19”,
and “It makes me uncomfortable to think about coronavirus-19”.
Eur. J. Investig. Health Psychol. Educ. 2021, 11 1048
2.3.5. Coronavirus Anxiety Scale (CAS)
This scale was developed with the purpose of studying the mental health response to
COVID-19 [41]. The scale was validated in the Portuguese population by Magano et al. [13].
According to the author [41], an instrument to quickly identify cases of dysfunctional
anxiety and symptom severity associated with the coronavirus was needed. This is a
five-item scale, answered in a 5-point Likert scale (0—not at all to 4—nearly every day
over the last 2 weeks) that assesses distinct physiological reactions of anxiety related to
the coronavirus, which was highly reliable as a cluster (α = 0.93) [41]. Examples of the
items are: “I felt dizzy, lightheaded, or faint, when I read or listened to news about the
coronavirus”, and “I had trouble falling or staying asleep because I was thinking about the
coronavirus”.
2.4. Analytic Approach
One-half of the study’s data were used for exploratory factor analysis (EFA) and the
other half for confirmatory factor analysis (CFA), to address the sampling error influences.
The EFA was used to test the authors’ models, while a CFA was used to test the EFA
results’ replicability. Convergent validity was calculated by composite reliability (CR) and
average variance extracted (AVE) values. Discriminant validity was assessed by square
roots of the AVE values and their comparison with the C19PRS and C19PS dimensions’
cross-correlations. EFA was assessed by correlation matrix (>r = 0.30 and <r = 0.90) (Yong
and Pearce [42]), determinant score > 0.00001, Bartlett’s Test of Sphericity (p < 0.001), the
Kaiser–Meyer–Olkin measure (KMO) of sampling adequacy (>0.50), diagonal element of
the anti-correlation matrix (>0.50), maximum likelihood factor analysis (>0.40), Kaiser’s
criterion of eigenvalues (>1) [42], structure coefficients (>0.40), communality coefficients
(<0.40) and Cronbach’s alpha (>0.70). CFA was assessed by Chi-square (χ2 < 2.00), Com-
parative Fit Index (CFI > 0.90), Tucker–Lewis Index (TLI > 0.90), root mean square error
of approximation (RMSEA < 0.06), PCLOSE (>0.05) and standardized root mean square
residual (SRMR < 0.06) [43]. The AVE should be equal to or greater than 0.50, the CR
greater than 0.70, and the square roots of AVE should be greater than the correlations
between constructs [44]. Statistical analysis was performed using SPSS version 27.0, and
confirmatory factor analysis (CFA) was run using AMOS version 27.0.
3. Results
3.1. Study 1
3.1.1. Exploratory Factorial Analysis (EFA) Results: COVID-19 Perceived Risk Scale
(C19PRS)
Several procedures have been carried out to determine whether the data are suitable
for EFA: in the correlation matrix, items three and four presented several correlations below
r = 0.30 with other items; so, according to Yong and Pearce [45], they should be removed,
as they indicated a lack of patterned relationships. None of the correlations between items
were above r = 0.90, suggesting a lack of multicollinearity; also, the determinant score
was above the rule of thumb of 0.00001 (0.04), indicating an absence of multicollinearity.
Bartlett’s Test of Sphericity (1753.124; default freedom = 28; p < 0.001) confirmed that our
items had patterned relationships amongst the variables (p < 0.001). Finally, looking at
the Kaiser–Meyer–Olkin measure (KMO) of sampling adequacy (cut-off above 0.50; in
our study 0.77) and the diagonal element of the anti-correlation matrix (cut-off of above
0.50), which ranged between 0.64 and 0.84, it was found that the sample was suitable
for EFA. The eight items of the C19PRS scale were subjected to an EFA with varimax
rotation. In the maximum likelihood factor analysis, the cut-off point was 0.40 and the
Kaiser’s criterion of eigenvalues was greater than one (Field, 2009), suggesting a two-factor
solution and accounting for 62.15% of the total variance explained. The eight items were
psychometrically robust (Table 2). The structure coefficients ranged from 0.67 to 0.84, and
communality coefficients ranged from 0.47 to 0.74. These items were reliable as a single
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dimension (α = 0.80) (if item 3 was deleted, the alpha’s value increased to 0.82) and as
two-factor dimensions (first one α = 0.85; second one α = 0.68).
Table 2. C19PRS’s EFA results.
LD1 LD2 h2 M SD
Item 1 Likelihood of acquiring COVID-19 0.67 0.58 2.30 0.92
Item 2 Likelihood of acquiring COVID-19compared to other persons 0.76 0.64 2.05 0.90
Item 3 Likelihood of acquiring other diseases 0.67 0.47 1.13 1.05
Item 4 Likelihood of dying from COVID-19 0.69 0.50 0.97 0.99
Item 5 Worried about acquiring COVID-19 0.79 0.70 2.35 1.06
Item 6 Worried about a family membercontracting COVID-19 0.82 0.67 3.32 0.85
Item 7 Worried about COVID-19 occurring inyour region 0.81 0.68 2.58 1.05
Item 8 Worried about COVID-19 emerging as ahealth issue 0.84 0.74 2.79 1.02
Total CPRS 2.19 0.63
Factor 1 5, 6, 7, 8 items Emotional scale 2.76 0.83
Factor 2 1, 2, 3, 4 items Cognitive scale 1.61 0.69
Notes: LD = Structure coefficients; h2 = Extracted communality coefficients; M = Mean; SD = Standard deviation.
3.1.2. Confirmatory Factorial Analysis (CFA) Results: COVID-19 Perceived Risk Scale
(C19PRS)
A CFA was performed to test the model found in the EFA. The results did not sup-
port the EFA findings (Figure 1). A poor model fit was found (χ2(19) = 114.59, p < 0.001)
with a poor fit for all of indices (χ2/df ratio = 6.03; CFI = 0.94; TLI = 0.92; SRMR = 0.06;
RMSEA = 0.10; PCLOSE = 0.00). When modification indices were analyzed, it was found
that the establishment of several correlations was suggested, the first one being the cor-
relation between the error of item 3 and the error of item 4. However, the standardized
regression weight of item 3 was 0.24, which is well below the recommended value (≥0.50).
The same happened with item 4. The decision to remove items 3 and 4 from the model
was made (Figure 2). This model presented a good fit (χ2(8) = 12.57, p < 0.001) with a
god fit for all of indices (χ2/df ratio = 1.57; CFI = 0.99; TLI = 0.99; SRMR = 0.01; RM-
SEA = 0.03; PCLOSE = 0.80) (Figure 2). Additionally, the value of Cronbach’s alpha for
the total scale with six items was 0.84; for the COVID-19 emotional perceived risk scale
(four items) it was 0.85, and for the COVID-19 cognitive perceived risk scale (two items)
it was 0.81. To test whether the C19PRS construct was measured the same way across
genders (women vs. men), a multigroup CFA was performed. The results demonstrated
gender differences, which were evidenced by the model fit (χ2(16) = 35.09, p = 0.04) (χ2/df
ratio = 2.19; CFI = 0.99; TLI = 0.98; SRMR = 0.02; RMSEA = 0.04; PCLOSE = 0.77). Women
(M = 2.76; SD = 0.70) presented significantly higher levels of COVID-19 perceived risk than
men (M = 2.39; SD = 0.76).
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correlation coefficient was used to estimate the convergent validity (Table 3), as usual in
similar cases. The C19PRS Total, Cognitive and Emotional correlated significantly with all
the other dimensions, except C19PRS Cognitive, which did not correlate with CAS Total.
Table 3. Spearman correlations between C19PRS dimensions and FC19S and CAS.
1 2 3 4 5 6 7
1 C19PR Total 1
2 C19PR Cognitive 0.66 ** 1
3 C19PR Emotional 0.85 ** 0.35 ** 1
4 FCV-19S Total 0.55 ** 0.18 ** 0.58 ** 1
5 FC19S Emotional fear 0.60 ** 0.20 ** 0.64 ** 0.92 ** 1
6 FC19S Cognitive fear 0.34 ** 0.12 ** 0.34 ** 0.83 ** 0.58 ** 1
7 CAS Total 0.24 ** 00.07 0.29 ** 0.50 ** 0.37 ** 0.51 ** 1
Notes: C19PRS—COVID-19 Perception Risk Scale; FC19S—Fear of COVID-19 Scale; CAS—COVID-19 Anxiety
Scale. ** The correlation is significant at the 0.01 level.
3.1.3. Convergent and Discriminant Validity
Table 4 presents inter-item correlations along with convergent and discriminant va-
lidity coefficients. Convergent validity was calculated by assessing composite reliability
(CR) and average variance extracted (AVE) values. The AVE and CR results are higher than
the thresholds of 0.50 and 0.70, respectively [46], and each factor significantly correlated
with the other (p < 0.01). The square roots of the AVE values (reported in the off-diagonal,
Table 4) being higher than the cross-correlations, the discriminant validity of the Cl9PS was
guaranteed.
Table 4. C19PRS convergent and discriminant validity.
AVE CR F1 F2
Factor 1 Cognitive factor 0.80 0.89 0.89 **
Factor 2 Emotional factor 0.67 0.89 0.43 ** 0.82 **
Notes: ** p < 001; AVE = average variance extracted; CR = composite reliability.
3.2. Study 2
3.2.1. Exploratory Factorial Analysis (CFA) Results: COVID-19 Phobia Scale (C19PS)
To determine whether the data are suitable for EFA, several procedures have been
carried out: in the correlation matrix, items three and four presented several correlations
below r = 0.30 with other items; so, according to Yong and Pearce [45], they had to be
removed, as they indicated a lack of patterned relationships. No correlations between items
were above r = 0.90, suggesting the lack of multicollinearity; also, the determinant score
was above the rule of thumb of 0.00001 (0.04), indicating an absence of multicollinearity.
Bartlett’s Test of Sphericity (6459.25; default freedom = 190; p < 0.001) confirmed that our
items had patterned relationships amongst the variables (p < 0.001). Finally, looking at
the Kaiser–Meyer–Olkin measure (KMO) of sampling adequacy (cut-off above 0.50; in our
study 0.93) and the diagonal element of the anti-correlation matrix (cut-off of above 0.50),
which ranged between 0.86 and 0.96, it was found that the sample was suitable for EFA.
An EFA with varimax rotation was performed with the 20 items of the C19PS scale. The
maximum likelihood factor analysis (with a cut-off point of 0.40 and the Kaiser’s criterion
of eigenvalues greater than 1 [42]) suggested a four-factor solution, explaining 65.18% of
total variance. The 20 items were psychometrically robust (Table 5). Structure coefficients
were saturated from 0.60 to 0.87, and communality coefficients were saturated from 0.32
(item 6) to 0.85 (item 8). These items were reliable as a unique dimension (α = 0.92) and as
a four-factor dimension (if item 6 was deleted from Factor 2, the alpha’s value increased
to 0.87) (Table 5). In this analysis, the items’ distributions followed the proposal of the
original version, except for item 20, which, in the original version, saturated in factor 4,
and in this study, saturated in factor 1.
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Table 5. C19PS’s EFA results.
LD1 LD2 LD3 LD4 h2 M SD
Item 1 Psychological factors 1 0.70 0.67 3.33 1.05
Item 2 Psychological factors 2 0.74 0.58 4.23 0.88
Item 3 Psychological factors 3 0.72 0.64 3.24 1.04
Item 4 Psychological factors 4 0.77 0.68 3.59 1.00
Item 5 Psychological factors 5 0.74 0.68 3.32 1.07
Item 6 Psychological factors 6 0.44 0.32 3.26 1.11
Item 7 Psycho-somatic factors 1 0.84 0.77 1.75 0.87
Item 8 Psycho-somatic factors 2 0.87 0.85 1.81 0.95
Item 9 Psycho-somatic factors 3 0.87 0.83 1.69 0.85
Item 10 Psycho-somatic factors 4 0.80 0.73 1.85 0.98
Item 11 Psycho-somatic factors 5 0.60 0.57 2.20 1.13
Item 12 Economic factors 1 0.80 0.79 2.33 1.05
Item 13 Economic factors 2 0.73 0.74 2.41 1.08
Item 14 Economic factors 3 0.68 0.60 1.65 0.83
Item 15 Economic factors 4 0.70 0.69 1.77 0.88
Item 16 Social factors 1 0.65 0.62 2.80 1.06
Item 17 Social factors 2 0.80 0.67 2.84 1.12
Item 18 Social factors 3 0.55 0.43 3.19 1.13
Item 19 Social factors 4 0.62 0.55 3.18 1.19
Item 20
Social factors 5 (original study)
Psycho-somatic factors 5
(this study)
0.53 0.62 2.35 1.07
α M SD
Total C19PS 0.92 2.64 0.65
Factor 1 7, 8, 9, 10, 11, 20 items Psychologicalfactors 0.91 1.94 0.81
Factor 2 1, 2, 3, 4, 5, 6 items Psychosomatic factors 0.86 3.50 0.78
Factor 3 12, 13, 14, 15 items Economic factors 0.82 2.04 0.78
Factor 4 16, 17, 18, 19 items Social factors 0.73 3.00 0.84
Notes: LD = Structure coefficients; h2 = Extracted communality coefficients; M = Mean; SD = Standard deviation;
α = Cronbach’s alpha.
3.2.2. Confirmatory Factorial Analysis (CFA) Results: COVID-19 Phobia Scale (C19PS)
A CFA was performed to test the model found in EFA. The results did not support
the EFA findings (Figure 3). A poor model fit was found (χ2(169) = 1130.27, p < 0.001)
with a poor fit for all indices (χ2/df ratio = 6.69; CFI = 0.86; TLI = 0.84; SRMR = 0.09;
RMSEA = 0.10; PCLOSE = 0.00). When the modification indices were analyzed, several
correlations between item errors were suggested; most of them were established within
each factor, but some occurred between item errors within different factors. From a
theoretical point of view, in all cases, there was content proximity. After the correlations
were established, this model presented a good fit (χ2(149) = 379.67, p < 0.001) with a god fit
for almost all indices (χ2/df ratio = 2.55; CFI = 0.97; TLI = 0.96; SRMR = 0.01; RMSEA = 0.05;
PCLOSE = 0.25) (Figure 4). To test if the C19PS construct was measured the same way
across genders (women vs. men), a multigroup CFA was performed. The results show
gender differences (χ2(16) = 547.91, p = 0.01) (χ2/df ratio = 1.84; CFI = 0.96; TLI = 0.95;
SRMR = 0.02; RMSEA = 0.04; PCLOSE = 1.00). Women (M = 2.72; SD = 0.64) presented
significantly higher levels of COVID-19 phobia than men (M = 2.48; SD = 0.64).
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Notes: C19PS—COVID-19 Phobia Scale; FC19S—Fear of COVID-19 Scale; C19PRS—COVID-19 Perception Risk Scale; 
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3.2.3. Convergent and Discriminant Validity
Table 7 presents inter-item correlations along with convergent and discriminant valid-
ity coeffi ients. Convergent validity was assessed via the composite reliability (CR) and
average variance extracted (AVE) values. The AVE and CR are higher than the thresholds of
0.50 and 0.70, respectively [46], except for the AVE in the psychosomatic and social factors.
Each factor significantly correlated with the other factors (p < 0.01). All square roots of
the AVE values (in the off-diagonal, Table 7) were higher than the cross-correlations; so,
discriminant validity of the Cl9PS was guaranteed.
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Table 7. C19PS convergent and discriminant validity.
AVE CR F1 F2 F3 F4
Factor 1 Psychological factors 0.58 0.89 0.76 **
Factor 2 Psychosomatic factors 0.48 0.84 0.582 ** 0.69 **
Factor 3 Economic factors 0.53 0.82 0.605 ** 0.479 ** 0.73 **
Factor 4 Social factors 0.43 075 0.490 ** 0.612 ** 0.432 ** 0.66 **
Notes: ** p < 0.001; AVE = average variance extracted; CR = composite reliability.
4. Discussion
The psychological impact of the COVID-19 pandemic has been studied by different
authors with the aim of improving the psychological assessment and intervention of people
most affected by COVID-19. To this end, validated instruments are needed to diagnose
and intervene in a timely and appropriate manner. Therefore, the aim of this study was
to validate two instruments for the general Portuguese population, using a sample of
Portuguese adults: COVID-19 Perceived Risk Scale (C19PRS) [14] and COVID-19 Phobia
scale (C19PS) [15].
The validation of the C19PRS did not confirm the original structure proposed by
the authors (eight items evenly distributed by two factors). In fact, the structure of this
construct, in the Portuguese version, excludes two items (item 3 and item 4) from factor 1
(cognitive), with factor 2 (emotional) remaining the same as the original. In the Portuguese
version, it is suggested that the C19PRS be a multidimensional scale, including cognitive
and emotive aspects of perceived personal risk related to COVID-19. The Portuguese
version showed good internal consistency, reliability, convergent validity, and evidence of
gender differences in the C19PRS total and subscales.
C19PRS correlates positively and significantly with fear, anxiety, and phobia related
to COVID-19: the higher the perceived risk of contracting COVID-19, the higher the fear,
anxiety, and phobia in relation to COVID-19. These results corroborate those of Amin [26],
Arpaci et al. [15], Cori et al. [18], Ho et al. [10], Lee [41], Lee and Crunk [28], Lee et al. [27],
Magano et al. [13], Paulino et al. [7], Wang et al. [47], Yıldırım and Güler [14] and Zhong
et al. [19]. Deng and colleagues [9] found that most COVID-19 patients experience de-
pression, anxiety, and sleep disturbances. Cielo and colleagues [11] found a negative
psychological impact on, and high vulnerability in, the young in the context of developing
psychological distress. The adaptation of the C19PS [15] confirmed the original structure
proposed by the authors (20 items distributed by four factors—psychological, psychoso-
matic, economic, and social factors), although item 20 (“I am unable to curb my anxiety
of catching coronavirus from others”), in the original version, saturated in factor 4 (social
factor), and in this study, it saturated in factor 1 (psychosomatic factor). In fact, the content
of the item can be referred to as a social factor (getting the virus from others), but it can also
be addressed as a psychosocial factor (I can’t control the anxiety). In our study, this item
clearly saturated in the psychosomatic factor and, in addition, if it was removed from this
factor, the value of the Cronbach’s alpha decreased. Therefore, the authors decided to
keep it in this factor. Good model adjustment was obtained only after the establishment of
several correlations between item errors. The Portuguese version showed good internal
consistency, reliability, convergent validity, and evidence of gender differences in the C19PS
total and its subscales. C19PS correlates positively and significantly with fear, anxiety, and
risk perception related to COVID-19: the higher the phobia of COVID-19, the higher the
fear, anxiety, and risk perception in relation to COVID-19. These results are also in line
with those of Amin [26], Arpaci et al. [15], Ho et al. [10], Lee [41], Lee and Crunk [28],
Lee et al. [27], Magano et al. [13], Paulino et al. [7], Toprak Celenay et al. [29], and Wang
et al. [47].
Gender differences were found in the values of C19PRS and C19PS, with women
scoring higher, which is in line with the results of Cihan and Durmaz [30], who found
phobia scores significantly higher in women. Additionally, Rodriguez-Besteiro et al. [48]
found that females presented a higher perception of danger (assessed by the risk perception
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scale) related to the COVID-19 virus than males. Concerning age, Bruine de Bruin [22] and
He and colleagues [23] found that older people perceived larger risks of dying from getting
COVID-19, but perceived less risk of getting COVID-19, getting quarantined, or running
out of money, as well as less depression and anxiety.
The implications of this study include the empowerment of Portuguese psychologists,
who now have an instrument to assess COVID-19-related risk perception and phobia.
Future studies with these instruments should be based on representative samples of the
Portuguese population.
This study presents some limitations: (1) the participants belong to the general Por-
tuguese population, but they are not representative of it; (2) the perceived risk and phobia
related to COVID-19 are self-reported, and some respondents may have provided the
desired social responses; (3) the professional distribution in the present study was unequal,
with 83.1% active, which might affect the psychometric evaluation; finally, (4) convenience
sampling may skew the results.
5. Conclusions
This study demonstrated that the C19RPS and the C19PS are robust instruments with
good psychometric properties to assess, respectively, risk perception and phobia related
to COVID-19 in the Portuguese population. Henceforth, Portuguese psychologists have
an instrument to assess COVID-19-related risk perception and phobia, validated for the
general Portuguese population.
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Appendix A. Coronavirus-19 Perceived Risk Scale
Portuguese Version
Por favor, leia cada uma das afirmações a seguir e escolha a resposta que melhor o(a)
descreve.
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1. Qual considera que é a probabilidade de contrair
COVID-19?     
2. Qual considera que é a probabilidade de contrair
COVID-19 em comparação com outras pessoas?     
3. Qual considera que é a probabilidade de contrair
outras doenças (por exemplo, diabetes/asma)?     
4. Qual considera que é a probabilidade de morrer
devido ao COVID-19?     
5. Quão preocupado está com a possibilidade de
contrair COVID-19?     
6. Quão preocupado está com o facto de um familiar
contrair COVID-19?     
7. Quão preocupado está com a ocorrência de
COVID-19 na sua região?     
8. Quão preocupado está com facto do COVID-19
emergir como um problema de saúde?     
Appendix B. Coronavirus-19 Phobia Scale
Portuguese Version
Por favor, assinale a sua concordância ou discordância em relação às seguintes afir-
mações:










1. O medo de contrair o coronavírus deixa-me
muito ansioso(a).     
2. Tenho muito medo que alguém da minha
família seja infetado pelo coronavírus.     
3. Notícias sobre mortes relacionadas com o
coronavírus causam-me grande ansiedade.     
4. As incertezas à volta do coronavírus causam-me
uma enorme ansiedade.     
5. A velocidade com que o coronavírus se
espalhou provoca-me um grande pânico.     
6. Discuto apaixonadamente (ou quero discutir)
com pessoas que considero que se comportam de
maneira irresponsável face ao coronavírus.
    
7. Tenho sérias dores de estômago por sentir medo
do coronavírus.     
8. Sinto uma forte dor no peito devido ao medo do
coronavírus.     
9. Tenho tremores devido ao medo do coronavírus.     
10. Tenho problemas de sono por causa do medo
do coronavírus.     











11. O coronavírus deixa-me tão tenso que me sinto
incapaz de fazer o que fazia antes sem problemas.     
12. A possibilidade de escassez de alimentos
devido à pandemia do coronavírus causa-me
ansiedade.
    
13. A possibilidade de falta de material de limpeza
e higiene devido à pandemia de coronavírus
causa-me ansiedade.
    
14. Eu estou a armazenar comida com medo do
coronavírus.     
15. Depois da pandemia de coronavírus, não me
sinto relaxado(a) a menos que verifique
constantemente os meus mantimentos em casa.
    
16. Após a pandemia de coronavírus, fico
extremamente ansioso(a) quando vejo pessoas a
tossir.
    
17. Após a pandemia de coronavírus, evito
ativamente as pessoas que vejo a espirrar.     
18. Após a pandemia do coronavírus, percebi que
passo longos períodos de tempo a lavar as mãos.     
19. O medo de contrair o coronavírus interfere
seriamente nas minhas relações sociais.     
20. Não consigo controlar a minha ansiedade de
contrair o coronavírus através de outras pessoas.     
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